Industry: Healthcare

SANYTOL, SANITIX, SANITIEN are confusingly similar, General Court rules

This positive ruling for hygiene brands is a reminder that applicants must be cautious in adopting parts of registered marks, particularly if the identical part is at the beginning, as only differing the end-syllable is not a guarantee of preventing infringement.

21 August 2024

ASCI report indicates need for stronger scrutiny and regulation in healthcare advertising

The ASCI’s Annual Complaints Report 2023-2024 reveals crucial insights into brand advertising campaigns in India, with 98% of scrutinised ads requiring modification. Misleading ads present a challenge for law enforcement and brands must adhere to court rulings or else risk the suspension of their manufacturing licences.

15 August 2024

DC Circuit decision brings copyright infringement exemptions before the courts

Copyright owners will be able to challenge DMCA exemptions, although overturning them will still be difficult, says expert.

10 July 2024

JPO finds no similarity between SOFTWEAR and SOFTWAIR

A key factor in the JPO Appeal Board’s decision was that SOFTWAIR has three possible pronunciations. 

10 June 2024

Bosch to expand Origify anti-counterfeiting technology to benefit luxury and FMCG brands

As Bosch’s authentication technology looks to expand into the luxury and FMCG markets, WTR asks whether a greater uptake would make it truly game-changing in the fight against fakes.

28 March 2024

Sanofi’s collegiate approach to combatting genericism  

Representatives from global healthcare company Sanofi speak to WTR about their recent efforts to protect the company's NANOBODY trademark from genericism. 

05 February 2024

Supreme Court issues landmark decision on criteria for dilution under Trademark Act

This victory for the LEGO Group will have significant implications for all owners of very famous trademarks. 

26 January 2024

The forefront of pharma: introduction

Featured in WTR and IAM Special Report Q4 2023: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Apollo Therapeutics

Featured in WTR and IAM Special Report Q4 2023: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Royalty Pharma

Featured in WTR and IAM Special Report Q4 2023: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Unlock unlimited access to all WTR content